plumbagin has been researched along with Disease Models, Animal in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 15 (88.24) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Davis, CD; Navalta, JW; Pile, JE; Sharma, NC | 1 |
Chen, CJ; Chen, WY; Chen, YF; Huang, WC; Liao, SL; Lin, SY; Pan, PH; Wang, YY | 1 |
Aru, DN; Bharne, AP; Kokare, DM; Nakhate, KT; Verma, VS | 1 |
Bawankule, DU; Gupta, AC; Maurya, AK; Mohanty, S; Saxena, A | 1 |
Abdelsalam, RM; El-Tanbouly, DM; Zaki, AM; Zaki, HF | 1 |
Dang, M; Lin, Y; Shao, Y; Xue, F | 1 |
Checker, R; Menon, J; Patwardhan, RS; Poduval, TB; Sainis, KB; Sandur, SK; Sharma, D; Thoh, M | 1 |
Chaijaroenkul, W; Karbwang, J; Na-Bangchang, K; Plengsuriyakarn, T; Sumsakul, W; Viyanant, V | 1 |
Da, Y; Ge, Z; Hao, J; Li, W; Li, Y; Liu, Y; Peng, M; Wang, D; Wang, H; Xue, Z; Yao, Z; Zhang, H; Zhang, K; Zhang, L; Zhang, R | 1 |
Checker, R; Gambhir, L; Kumar, M; Sandur, SK; Sharma, D | 1 |
Fan, QM; Han, XG; Liu, XQ; Qiao, H; Qin, A; Tang, TT; Wang, TY; Wang, YG; Yu, ZF | 1 |
Banerji, A; Baranwal, G; Biswas, R; Bose, C; Chatterjee, M; Nair, SV; Sachu, A; Vasudevan, AK | 1 |
Chuang, YM; Dutta, NK; Hung, CF; Karakousis, PC; Rubin, H; Wu, TC | 1 |
Gowda, R; Kardos, G; Robertson, GP; Sharma, A; Singh, S | 1 |
Arumugam, TV; Camandola, S; Cutler, RG; Greig, NH; Johnson, DA; Johnson, JA; Luo, W; Mattson, MP; Moore, TA; Mughal, MR; Son, TG; Telljohann, RS; Yu, QS | 1 |
Fischer, JW; Hafeez, BB; Mustafa, A; Verma, AK; Witkowsky, O; Zhong, W | 1 |
Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V | 1 |
17 other study(ies) available for plumbagin and Disease Models, Animal
Article | Year |
---|---|
Interventional effects of plumbagin on experimental ulcerative colitis in mice.
Topics: Animals; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Interleukin-17; Male; Mice; Molecular Structure; Naphthoquinones; Tumor Necrosis Factor-alpha | 2013 |
Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats.
Topics: Animals; Bile Acids and Salts; Bile Ducts; Cholestasis; Disease Models, Animal; Ligation; Liver; Naphthoquinones; NF-E2-Related Factor 2; Rats | 2022 |
Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer's disease via activation of Nrf2/ARE pathway and inhibition of β-secretase.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antioxidant Response Elements; Cerebral Cortex; Cognition Disorders; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Mice; Naphthoquinones; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Streptozocin | 2018 |
Plumbagin, a vitamin K3 analogue ameliorate malaria pathogenesis by inhibiting oxidative stress and inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antimalarials; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Malaria; Male; Mice; Naphthoquinones; Oxidative Stress; Plasmodium berghei; Plumbaginaceae | 2018 |
Plumbagin ameliorates hepatic ischemia-reperfusion injury in rats: Role of high mobility group box 1 in inflammation, oxidative stress and apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Cytoprotection; Disease Models, Animal; Enzymes; Glutathione; Glutathione Peroxidase; Hepatitis; HMGB1 Protein; Inflammation Mediators; Lipid Peroxidation; Liver; Male; Naphthoquinones; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2018 |
Evaluation of wound healing activity of plumbagin in diabetic rats.
Topics: Animals; Antioxidants; Collagen; Collagen Type I; Diabetes Mellitus, Experimental; Disease Models, Animal; Insulin; Male; Naphthoquinones; Rats; Rats, Wistar; Skin; Wound Healing | 2019 |
Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Liver; Lung; Macrophages; Male; Mice; Naphthoquinones; NF-kappa B; Nitric Oxide; Oxidative Stress; Shock, Septic; Signal Transduction; Spleen; Time Factors; Tumor Necrosis Factor-alpha | 2014 |
Antimalarial activity of plumbagin in vitro and in animal models.
Topics: Animals; Antimalarials; Biological Availability; Body Weight; Chloroquine; Disease Models, Animal; Female; In Vitro Techniques; Malaria; Male; Mice; Mice, Inbred ICR; Naphthoquinones; Plasmodium berghei; Plasmodium falciparum; Toxicity Tests | 2014 |
Plumbagin suppresses dendritic cell functions and alleviates experimental autoimmune encephalomyelitis.
Topics: Adjuvants, Immunologic; Animals; Antigens, CD; Apoptosis; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Cytokines; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Endocytosis; Female; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Naphthoquinones; Spinal Cord | 2014 |
Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2).
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Disease Models, Animal; Dual Specificity Phosphatase 1; Dual-Specificity Phosphatases; Enzyme Activation; Glutathione; Humans; Jurkat Cells; Lymphoma, T-Cell; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Phosphatases; Models, Molecular; Naphthoquinones; Oxidative Stress; Phosphorylation; Random Allocation | 2015 |
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
Topics: Adenine Nucleotides; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Drug Synergism; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Osteoclasts; Osteolysis; Phosphorylation; Random Allocation; Signal Transduction; Zoledronic Acid | 2016 |
Antimicrobial activity of plumbagin, a naturally occurring naphthoquinone from Plumbago rosea, against Staphylococcus aureus and Candida albicans.
Topics: Animals; Anti-Infective Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Drosophila melanogaster; Female; Microbial Sensitivity Tests; Naphthoquinones; Phytochemicals; Plumbaginaceae; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome | 2016 |
Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.
Topics: Acid Anhydride Hydrolases; Animals; Antitubercular Agents; Biofilms; Citric Acid Cycle; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Gene Expression; Glycerophosphates; Isoenzymes; Isoniazid; Meropenem; Mice; Mycobacterium tuberculosis; Naphthoquinones; Phosphotransferases (Phosphate Group Acceptor); Polyphosphates; Thienamycins; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Vaccines, DNA; Xylose | 2016 |
Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Compounding; Drug Stability; Drug Synergism; Female; Humans; Liposomes; Melanoma; Mice; Nanoparticles; Naphthoquinones; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Embryo, Mammalian; Gene Expression Regulation; Glucose; Heme Oxygenase-1; Humans; Hypoxia; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Naphthoquinones; Neuroblastoma; Neurologic Examination; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Transfection | 2010 |
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antigens, Polyomavirus Transforming; Chromogranin A; Disease Models, Animal; Male; Mice; Mice, Transgenic; Naphthoquinones; Phosphorylation; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Kinase C-epsilon; STAT3 Transcription Factor; Synaptophysin | 2012 |
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts | 1992 |